Chris Coloian

As Executive Vice President of Revenue and Growth, Chris is responsible for driving Cotiviti’s growth, leading its sales, marketing, product and government teams. As a healthcare veteran with more than 25 years of industry experience, Chris has held senior-level leadership positions across a variety of market segments, including healthcare services, health insurance operations, and management consulting. Most recently, he served as Chief Solutions Officer for Welltok, a fast-growth health technology company. Prior to Welltok, he was the CEO and founder of Predilytics, which was purchased by Welltok.

In addition, Chris has held leadership positions at several payer, provider, and healthcare services companies, including Health Dialog, Cigna HealthCare, and Matria Healthcare (now Alere). Chris currently sits on the board of directors of Regent Surgical Health and Emerson Hospital, serves on the advisory board of Jefferson University’s Public Health Program, and is an editor for Population Health Management.

Chris earned a master’s degree in health administration from The Ohio State University and a bachelor’s degree in zoology from Miami University.